Literature DB >> 11748597

EMDR: a putative neurobiological mechanism of action.

Robert Stickgold1.   

Abstract

Numerous studies have provided evidence for the efficacy of eye movement desensitization and reprocessing therapy (EMDR) in the treatment of posttraumatic stress disorder (PTSD), including recent studies showing it to be more efficient than therapist-directed flooding. But few theoretical explanations of how EMDR might work have been offered. Shapiro, in her original description of EMDR, proposed that its directed eye movements mimic the saccades of rapid eye movement sleep (REM), but provided no clear explanation of how such mimicry might lead to clinical improvement. We now revisit her original proposal and present a complete model for how EMDR could lead to specific improvement in PTSD and related conditions. We propose that the repetitive redirecting of attention in EMDR induces a neurobiological state, similar to that of REM sleep, which is optimally configured to support the cortical integration of traumatic memories into general semantic networks. We suggest that this integration can then lead to a reduction in the strength of hippocampally mediated episodic memories of the traumatic event as well as the memories' associated, amygdala-dependent, negative affect. Experimental data in support of this model are reviewed and possible tests of the model are suggested. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11748597     DOI: 10.1002/jclp.1129

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  38 in total

1.  Sexual violence: psychiatric healing with eye movement reprocessing and desensitization.

Authors:  Bobbie Posmontier; Tiffany Dovydaitis; Kenneth Lipman
Journal:  Health Care Women Int       Date:  2010-08

2.  Early-life trauma is associated with rapid eye movement sleep fragmentation among military veterans.

Authors:  Salvatore P Insana; David J Kolko; Anne Germain
Journal:  Biol Psychol       Date:  2012-01-18       Impact factor: 3.251

Review 3.  [EMDR as a psychotherapeutic approach in the treatment of chronic pain : Is Eye Movement Desensitization and Reprocessing an effective therapy for patients with chronic pain who do not suffer from posttraumatic stress disorder?]

Authors:  M Wicking; C Maier; J Tesarz; K Bernardy
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

4.  Neural correlates of experimental trauma memory retrieval.

Authors:  Geraldine A Gvozdanovic; Philipp Stämpfli; Erich Seifritz; Björn Rasch
Journal:  Hum Brain Mapp       Date:  2017-04-17       Impact factor: 5.038

Review 5.  Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence.

Authors:  Carla M Nappi; Sean P A Drummond; Joshua M H Hall
Journal:  Neuropharmacology       Date:  2011-03-17       Impact factor: 5.250

Review 6.  Sleep disturbances as the hallmark of PTSD: where are we now?

Authors:  Anne Germain
Journal:  Am J Psychiatry       Date:  2013-04       Impact factor: 18.112

7.  Quantitative electroencephalography during rapid eye movement (REM) and non-REM sleep in combat-exposed veterans with and without post-traumatic stress disorder.

Authors:  Daniel J Cohen; Amy Begley; Jennie J Alman; David J Cashmere; Regina N Pietrone; Robert J Seres; Anne Germain
Journal:  J Sleep Res       Date:  2012-07-30       Impact factor: 3.981

Review 8.  Sleep and the functional connectome.

Authors:  Dante Picchioni; Jeff H Duyn; Silvina G Horovitz
Journal:  Neuroimage       Date:  2013-05-24       Impact factor: 6.556

Review 9.  Sleep-dependent memory consolidation and reconsolidation.

Authors:  Robert Stickgold; Matthew P Walker
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

10.  Accelerated Resolution Therapy: Randomized Controlled Trial of a Complicated Grief Intervention.

Authors:  Harleah G Buck; Paula Cairns; Nnadozie Emechebe; Diego F Hernandez; Tina M Mason; Jesse Bell; Kevin E Kip; Philip Barrison; Cindy Tofthagen
Journal:  Am J Hosp Palliat Care       Date:  2020-01-21       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.